Package 71288-169-25

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "bb497b35-a3a3-43e8-a187-6ad2851acf26", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["240416"], "spl_set_id": ["8b366382-c8d1-4344-86b7-f65e92a8952b"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (71288-169-25)  / 25 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "71288-169-25", "marketing_start_date": "20220228"}], "brand_name": "Cytarabine", "product_id": "71288-169_bb497b35-a3a3-43e8-a187-6ad2851acf26", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "71288-169", "generic_name": "Cytarabine", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA208485", "marketing_category": "ANDA", "marketing_start_date": "20220228", "listing_expiration_date": "20261231"}